KRAS and pancreatic neoplasm: It was shown that silencing of Kras expression significantly reduced collagen I deposition in renal fibrosis, and together with the epithelial–mesenchymal transition (EMT) regulator, SNAIL, mutant Kras increased collagen formation by pancreatic cancer stellate cells (PCAS) [102,103].